Loading...
Header Logo
Keywords
Last Name
Institution

Joel Gore

Concepts (364)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
115
2017
711
11.800
Why?
Acute Coronary Syndrome
39
2017
172
5.670
Why?
Hospitalization
64
2016
641
4.600
Why?
Hospital Mortality
63
2016
525
3.770
Why?
Registries
54
2015
455
3.730
Why?
Aged
167
2017
7370
3.020
Why?
Middle Aged
151
2017
9556
2.560
Why?
Male
172
2017
16728
2.180
Why?
Female
171
2017
18121
2.080
Why?
Massachusetts
58
2016
1502
2.050
Why?
Electrocardiography
28
2015
285
1.940
Why?
Shock, Cardiogenic
11
2016
44
1.790
Why?
Heart Failure
19
2015
426
1.750
Why?
Humans
187
2017
33125
1.730
Why?
Coronary Artery Bypass
23
2015
244
1.720
Why?
Aged, 80 and over
62
2017
2777
1.720
Why?
Thrombolytic Therapy
15
2011
135
1.700
Why?
Angina, Unstable
15
2010
67
1.580
Why?
Heparin
4
2013
97
1.540
Why?
Risk Factors
54
2017
2896
1.520
Why?
Hypertension
12
2015
378
1.500
Why?
Anticoagulants
14
2015
214
1.490
Why?
Hemorrhage
15
2015
156
1.460
Why?
Warfarin
4
2015
79
1.430
Why?
Treatment Outcome
60
2017
2547
1.350
Why?
Time Factors
40
2017
2542
1.290
Why?
Emergency Medical Services
5
2016
125
1.290
Why?
Prognosis
36
2015
889
1.280
Why?
Age Factors
34
2016
1078
1.240
Why?
Risk Assessment
26
2015
1032
1.200
Why?
Incidence
29
2016
751
1.090
Why?
Patient Readmission
6
2015
154
1.070
Why?
Coronary Disease
9
2012
352
1.070
Why?
Inpatients
6
2012
141
1.050
Why?
Myocardial Reperfusion
4
2011
32
1.030
Why?
Thrombocytopenia
2
2012
38
1.030
Why?
Ambulances
2
2012
19
1.030
Why?
Myocardial Revascularization
13
2014
62
1.000
Why?
Retrospective Studies
34
2015
2411
0.980
Why?
Patient Discharge
14
2017
204
0.960
Why?
Fibrinolytic Agents
14
2012
142
0.950
Why?
Multivariate Analysis
26
2017
703
0.950
Why?
Platelet Aggregation Inhibitors
16
2014
220
0.900
Why?
Antihypertensive Agents
8
2015
132
0.900
Why?
Odds Ratio
25
2016
581
0.890
Why?
Survival Rate
24
2015
500
0.870
Why?
Diabetes Mellitus
7
2015
391
0.850
Why?
Logistic Models
19
2016
843
0.830
Why?
Heart Rate
3
2015
219
0.800
Why?
Angiotensin-Converting Enzyme Inhibitors
14
2015
114
0.790
Why?
Adrenergic beta-Antagonists
15
2014
125
0.780
Why?
Sex Factors
16
2015
643
0.760
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
5
2008
62
0.750
Why?
Residence Characteristics
6
2013
161
0.730
Why?
Autonomic Nervous System
1
2015
28
0.720
Why?
Body Mass Index
4
2015
713
0.720
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11
2014
145
0.720
Why?
Follow-Up Studies
22
2015
1524
0.710
Why?
Venous Thromboembolism
6
2012
92
0.700
Why?
Prospective Studies
25
2015
1582
0.700
Why?
Outcome Assessment (Health Care)
10
2014
436
0.660
Why?
Atrial Fibrillation
5
2012
177
0.650
Why?
Patient Acceptance of Health Care
4
2009
250
0.650
Why?
Heart
1
2015
212
0.630
Why?
Heart Arrest
3
2012
62
0.630
Why?
Acute Disease
23
2015
513
0.620
Why?
Length of Stay
13
2017
393
0.600
Why?
Coronary Artery Disease
5
2015
229
0.590
Why?
Stroke
14
2013
466
0.580
Why?
Kidney Diseases
3
2010
112
0.580
Why?
Transportation of Patients
2
2009
20
0.570
Why?
Insulin Resistance
1
2015
309
0.570
Why?
Ventricular Fibrillation
2
2008
29
0.570
Why?
Chest Pain
2
2010
33
0.560
Why?
Adult
25
2015
9330
0.550
Why?
Recurrence
13
2015
378
0.540
Why?
Myocardial Ischemia
5
2012
109
0.540
Why?
Academic Medical Centers
3
2015
170
0.540
Why?
Stroke Volume
4
2015
183
0.540
Why?
Cardiovascular Agents
9
2013
78
0.540
Why?
Polysaccharides
1
2012
81
0.540
Why?
Comorbidity
17
2015
703
0.530
Why?
Drug Dosage Calculations
1
2010
4
0.530
Why?
Hemangiosarcoma
1
2010
17
0.530
Why?
Obesity
3
2015
850
0.530
Why?
Pharmacogenetics
1
2010
20
0.530
Why?
Outpatient Clinics, Hospital
1
2010
36
0.520
Why?
Inflammation
2
2015
646
0.520
Why?
Heart Neoplasms
1
2010
26
0.520
Why?
Age Distribution
9
2014
216
0.520
Why?
Blood Coagulation
1
2010
32
0.520
Why?
Evidence-Based Medicine
10
2015
296
0.500
Why?
Aspirin
12
2014
160
0.500
Why?
Exercise
1
2015
530
0.500
Why?
Ticlopidine
5
2011
78
0.490
Why?
Practice Guidelines as Topic
7
2015
433
0.480
Why?
Chi-Square Distribution
8
2017
338
0.480
Why?
Blood Glucose
2
2014
381
0.480
Why?
Heparin, Low-Molecular-Weight
3
2010
27
0.460
Why?
Community Health Services
2
2010
103
0.460
Why?
Pulmonary Embolism
4
2010
111
0.460
Why?
Cause of Death
7
2014
119
0.440
Why?
Resuscitation Orders
2
2007
13
0.440
Why?
Sex Distribution
10
2014
214
0.420
Why?
Delivery of Health Care
1
2009
143
0.410
Why?
Survival Analysis
15
2014
393
0.400
Why?
Anticholesteremic Agents
2
2008
40
0.400
Why?
Cholesterol, LDL
2
2007
122
0.380
Why?
Severity of Illness Index
12
2015
807
0.370
Why?
Mortality
5
2012
77
0.370
Why?
Overweight
2
2011
169
0.360
Why?
Stents
8
2012
214
0.360
Why?
Longitudinal Studies
6
2017
695
0.360
Why?
September 11 Terrorist Attacks
1
2005
16
0.360
Why?
Europe
10
2013
113
0.350
Why?
Cross-Sectional Studies
8
2015
1183
0.350
Why?
Patient Transfer
2
2010
39
0.320
Why?
Diabetes Complications
3
2014
96
0.320
Why?
Health Services Accessibility
2
2005
279
0.310
Why?
Venous Thrombosis
4
2013
92
0.300
Why?
South America
7
2013
22
0.300
Why?
Disease Management
6
2009
95
0.300
Why?
Quality of Health Care
3
2010
358
0.290
Why?
North America
7
2013
76
0.290
Why?
Hypercholesterolemia
1
2002
86
0.280
Why?
Secondary Prevention
5
2014
95
0.270
Why?
Coronary Stenosis
2
2011
25
0.260
Why?
Patient Admission
3
2015
105
0.250
Why?
Medical Records
4
2012
116
0.250
Why?
Blood Pressure
6
2011
358
0.250
Why?
Survivors
3
2017
81
0.250
Why?
United States
13
2017
3859
0.240
Why?
New Zealand
8
2013
28
0.230
Why?
Australia
8
2013
49
0.230
Why?
Healthcare Disparities
2
2010
115
0.230
Why?
Calcium Channel Blockers
3
2015
68
0.230
Why?
Anemia
2
2011
59
0.220
Why?
Clinical Trials as Topic
4
2015
300
0.220
Why?
Young Adult
6
2015
2031
0.220
Why?
Drug Therapy, Combination
8
2012
344
0.220
Why?
Societies, Medical
3
2015
150
0.220
Why?
Primary Prevention
3
2014
95
0.220
Why?
Catheterization, Swan-Ganz
2
2009
10
0.220
Why?
Ventricular Function, Left
2
2009
132
0.210
Why?
Canada
6
2015
100
0.210
Why?
Cohort Studies
8
2015
1336
0.210
Why?
Drug Utilization Review
2
2007
52
0.210
Why?
Algorithms
2
2012
629
0.200
Why?
Proportional Hazards Models
7
2014
450
0.200
Why?
Research Design
4
2014
391
0.200
Why?
Arrhythmias, Cardiac
2
2009
70
0.200
Why?
Endpoint Determination
2
2014
25
0.200
Why?
Cardiovascular Diseases
3
2012
541
0.200
Why?
Delayed Diagnosis
1
2016
20
0.190
Why?
Syndrome
9
2007
120
0.190
Why?
Heart Block
2
2008
18
0.190
Why?
Exercise Test
2
2015
147
0.190
Why?
Data Collection
3
2009
369
0.190
Why?
Diuretics
1
2015
31
0.190
Why?
Forecasting
2
2014
164
0.190
Why?
Antiphospholipid Syndrome
1
2014
3
0.180
Why?
Streptokinase
3
2004
8
0.180
Why?
Chronic Disease
2
2015
527
0.170
Why?
Nutrition Surveys
1
2015
90
0.170
Why?
Cardiotonic Agents
2
2015
34
0.170
Why?
Urban Population
1
2015
148
0.170
Why?
Cardiomyopathies
1
2014
58
0.170
Why?
Recovery of Function
1
2015
112
0.170
Why?
Hyperglycemia
1
2014
90
0.170
Why?
Regression Analysis
5
2010
419
0.170
Why?
Inflammation Mediators
1
2015
134
0.170
Why?
Urban Health
2
2015
42
0.170
Why?
C-Reactive Protein
1
2015
167
0.160
Why?
Infusions, Intravenous
2
2011
131
0.160
Why?
Health Care Surveys
3
2010
234
0.160
Why?
Thinness
2
2011
26
0.160
Why?
Trauma Centers
1
2013
29
0.160
Why?
Hospitals, University
1
2013
39
0.160
Why?
Predictive Value of Tests
6
2015
647
0.160
Why?
Brain Ischemia
2
2013
177
0.160
Why?
Disease Progression
5
2014
471
0.160
Why?
Glomerular Filtration Rate
2
2010
63
0.150
Why?
Emergency Service, Hospital
3
2011
352
0.150
Why?
Databases, Factual
2
2012
379
0.150
Why?
Intensive Care Units
2
2011
186
0.150
Why?
Coronary Angiography
5
2010
144
0.150
Why?
Adolescent
4
2015
3942
0.150
Why?
Leg
1
2012
79
0.140
Why?
Treatment Failure
1
2012
118
0.140
Why?
Prevalence
5
2015
773
0.140
Why?
Cerebrovascular Disorders
1
2011
45
0.140
Why?
Hospitals, Community
2
2009
47
0.140
Why?
Postoperative Care
1
2011
74
0.140
Why?
Continuity of Patient Care
2
2014
114
0.140
Why?
Pyridines
2
2009
83
0.140
Why?
Aging
2
2008
516
0.130
Why?
Mixed Function Oxygenases
1
2010
14
0.130
Why?
Aryl Hydrocarbon Hydroxylases
1
2010
17
0.130
Why?
Vena Cava Filters
1
2010
15
0.130
Why?
Reproducibility of Results
2
2012
964
0.130
Why?
International Normalized Ratio
1
2010
38
0.130
Why?
Hypertrophy, Left Ventricular
1
2011
81
0.130
Why?
Hypotension
1
2010
32
0.130
Why?
Echocardiography
2
2009
192
0.130
Why?
Outcome and Process Assessment (Health Care)
2
2010
179
0.130
Why?
Heart Rupture
1
2010
1
0.130
Why?
Drug Prescriptions
2
2010
115
0.130
Why?
Thrombosis
1
2012
152
0.130
Why?
Kidney Failure, Chronic
1
2011
136
0.130
Why?
Randomized Controlled Trials as Topic
3
2007
316
0.130
Why?
Infection
1
2010
58
0.130
Why?
Nitrates
1
2009
13
0.130
Why?
Australasia
2
2013
7
0.130
Why?
Genetic Testing
1
2010
71
0.130
Why?
Professional Practice
1
2009
23
0.130
Why?
Renal Dialysis
1
2011
154
0.120
Why?
Drug Monitoring
1
2010
94
0.120
Why?
Metoprolol
1
2009
17
0.120
Why?
Multicenter Studies as Topic
4
2015
49
0.120
Why?
Gated Blood-Pool Imaging
1
2009
12
0.120
Why?
Patient Satisfaction
1
2011
245
0.120
Why?
Smoking
3
2011
800
0.120
Why?
Pulmonary Disease, Chronic Obstructive
1
2011
131
0.120
Why?
Body Weight
1
2011
340
0.120
Why?
Combined Modality Therapy
4
2015
295
0.120
Why?
Postoperative Complications
2
2011
559
0.120
Why?
Models, Cardiovascular
1
2009
51
0.120
Why?
Confidence Intervals
4
2010
237
0.120
Why?
Genotype
1
2010
486
0.120
Why?
American Heart Association
3
2015
57
0.110
Why?
Tachycardia, Ventricular
1
2008
21
0.110
Why?
Drug-Eluting Stents
1
2009
28
0.110
Why?
Health Services for the Aged
1
2008
33
0.110
Why?
Child
1
2015
2582
0.110
Why?
Time
1
2008
21
0.110
Why?
Dose-Response Relationship, Drug
4
2012
700
0.110
Why?
Angioplasty, Balloon
1
2008
41
0.110
Why?
Risk
1
2008
331
0.110
Why?
Phenotype
1
2010
779
0.110
Why?
Diagnostic Tests, Routine
1
2007
25
0.110
Why?
Enoxaparin
1
2007
12
0.110
Why?
Leukocyte Count
2
2004
76
0.100
Why?
Socioeconomic Factors
2
2015
571
0.100
Why?
Administration, Oral
3
2014
197
0.100
Why?
Population Surveillance
4
2010
181
0.100
Why?
Diabetes Mellitus, Type 2
1
2011
404
0.100
Why?
Peripheral Vascular Diseases
1
2007
45
0.100
Why?
Cardiology
1
2007
74
0.100
Why?
Statistics, Nonparametric
1
2007
168
0.100
Why?
Quality of Life
3
2017
439
0.100
Why?
Tomography, X-Ray Computed
1
2010
724
0.090
Why?
Azetidines
1
2005
4
0.090
Why?
Thrombin
1
2005
45
0.090
Why?
District of Columbia
1
2005
9
0.090
Why?
Magnetic Resonance Imaging
1
2010
844
0.090
Why?
New York City
1
2005
59
0.090
Why?
Drug Utilization
4
2009
146
0.090
Why?
Insurance, Health
2
2002
80
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2009
559
0.090
Why?
Intracranial Hemorrhages
1
2004
12
0.080
Why?
Neoplasms
1
2010
593
0.080
Why?
Resuscitation
1
2004
38
0.080
Why?
Diagnosis, Differential
1
2006
586
0.080
Why?
International Cooperation
1
2004
60
0.080
Why?
Leukocytosis
1
2003
9
0.080
Why?
Propensity Score
2
2014
58
0.080
Why?
Decision Support Techniques
1
2004
94
0.080
Why?
Qualitative Research
1
2004
146
0.080
Why?
Tissue Plasminogen Activator
1
2004
86
0.080
Why?
Nursing Homes
1
2006
292
0.080
Why?
Emergency Medicine
1
2002
73
0.070
Why?
Women's Health
1
2003
289
0.070
Why?
Life Style
2
2015
263
0.070
Why?
Cholesterol
1
2002
255
0.070
Why?
Hispanic Americans
1
2004
360
0.060
Why?
Health Status
2
2017
313
0.060
Why?
Creatinine
2
2010
86
0.060
Why?
Hematocrit
2
2011
39
0.060
Why?
Patient Selection
2
2011
281
0.050
Why?
Case-Control Studies
2
2014
631
0.050
Why?
Disease-Free Survival
1
2017
125
0.050
Why?
Disease Susceptibility
2
2007
91
0.050
Why?
Risk Adjustment
2
2008
70
0.050
Why?
Georgia
1
2015
30
0.050
Why?
Hypertension, Renal
1
2015
8
0.050
Why?
Diet, Sodium-Restricted
1
2015
7
0.050
Why?
Denervation
1
2015
9
0.050
Why?
Blood Pressure Determination
1
2015
20
0.050
Why?
Single-Blind Method
1
2015
65
0.050
Why?
Goals
1
2015
36
0.050
Why?
Internationality
1
2014
27
0.040
Why?
Exercise Therapy
1
2015
36
0.040
Why?
Fatal Outcome
1
2014
77
0.040
Why?
Cost of Illness
1
2015
89
0.040
Why?
Hemodynamics
1
2015
156
0.040
Why?
Americas
2
2004
4
0.040
Why?
Risk Reduction Behavior
1
2015
95
0.040
Why?
Sample Size
1
2014
34
0.040
Why?
Partial Thromboplastin Time
1
2013
11
0.040
Why?
Up-Regulation
1
2014
313
0.040
Why?
Drug Administration Schedule
1
2014
223
0.040
Why?
Cost-Benefit Analysis
1
2014
176
0.040
Why?
Demography
2
2004
152
0.040
Why?
United States Food and Drug Administration
1
2012
43
0.040
Why?
Renal Insufficiency
1
2012
42
0.040
Why?
Nitroglycerin
1
2011
18
0.040
Why?
Furosemide
1
2011
12
0.040
Why?
International Classification of Diseases
1
2012
82
0.040
Why?
Middle East
1
2011
7
0.040
Why?
Clonidine
1
2011
25
0.040
Why?
Perioperative Care
1
2011
36
0.040
Why?
Analysis of Variance
2
2004
542
0.040
Why?
Long-Term Care
1
2012
117
0.030
Why?
Angiotensin II Type 1 Receptor Blockers
1
2010
23
0.030
Why?
Piperazines
1
2011
94
0.030
Why?
Edema
1
2010
27
0.030
Why?
Heart Rupture, Post-Infarction
1
2010
3
0.030
Why?
New England
1
2010
196
0.030
Why?
Hematoma, Subdural
1
2009
2
0.030
Why?
Ontario
1
2010
43
0.030
Why?
Muscle Cells
1
2009
15
0.030
Why?
Dyspnea
1
2010
45
0.030
Why?
Ischemic Preconditioning, Myocardial
1
2009
22
0.030
Why?
Probability
1
2010
149
0.030
Why?
Nomograms
1
2009
7
0.030
Why?
Necrosis
1
2009
91
0.030
Why?
Injections, Intravenous
1
2009
145
0.030
Why?
Hospitals, Urban
1
2009
36
0.030
Why?
Epidemiologic Methods
1
2009
64
0.030
Why?
Cough
1
2010
120
0.030
Why?
Ventricular Dysfunction, Left
1
2009
88
0.030
Why?
Hospitals, Teaching
1
2009
83
0.030
Why?
Critical Care
1
2010
134
0.030
Why?
Adaptation, Psychological
1
2009
157
0.030
Why?
Drug Information Services
1
2007
6
0.030
Why?
Aftercare
1
2007
19
0.030
Why?
Patient Rights
1
2007
16
0.030
Why?
Metabolic Clearance Rate
1
2007
49
0.030
Why?
Laboratories
1
2007
19
0.030
Why?
Life Expectancy
1
2007
16
0.030
Why?
Ultrasonography
1
2008
291
0.030
Why?
Geriatrics
1
2007
23
0.030
Why?
Life Tables
1
2007
24
0.030
Why?
Prejudice
1
2007
43
0.030
Why?
Angina Pectoris
1
2006
44
0.030
Why?
Creatine Kinase, MB Form
1
2006
11
0.020
Why?
Troponin
1
2006
21
0.020
Why?
Creatine Kinase
1
2006
42
0.020
Why?
Drug Therapy
1
2006
46
0.020
Why?
Heart Diseases
1
2007
135
0.020
Why?
Benzylamines
1
2005
9
0.020
Why?
Kidney
1
2007
276
0.020
Why?
Epidemiologic Studies
1
2005
34
0.020
Why?
Thromboembolism
1
2005
40
0.020
Why?
Arthroplasty, Replacement, Hip
1
2005
44
0.020
Why?
Withholding Treatment
1
2004
31
0.020
Why?
Arthroplasty, Replacement, Knee
1
2005
63
0.020
Why?
Cardiac Output, Low
1
2003
8
0.020
Why?
Argentina
1
2002
3
0.020
Why?
Brazil
1
2002
41
0.020
Why?
Blood Vessel Prosthesis Implantation
1
2003
114
0.020
Why?
European Continental Ancestry Group
1
2004
401
0.020
Why?
Social Class
1
2002
77
0.020
Why?
Hospitals
1
2002
171
0.020
Why?
Gore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_